← Open Payments lookup

KRISTEN RIDGEWAY: Open Payments

NPI 1346964897 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,373 in 58 payments from 22 companies in 2025. Trend: 2023 $1,034 · 2024 $1,402 · 2025 $1,373

Food & beverage: $1,373
CompanyPaymentsAmount
Janssen Biotech, Inc.9$227
Novartis Pharmaceuticals Corporation9$190
AstraZeneca Pharmaceuticals LP7$155
Genentech USA, Inc.4$89
Gilead Sciences, Inc.3$82
PharmaEssentia USA Corporation3$79
Lilly USA, LLC3$79
ABBVIE INC.3$75
Genmab U.S., Inc.2$52
Merck Sharp & Dohme LLC2$50

Products named: RYBREVANT, SCEMBLIX, Trodelvy, BESREMI, VERZENIO, ENHERTU, Itovebi, Epkinly.

Industry payments across MD — which companies pay providers there.